Nirmatrelvir + ritonavir (Paxlovid)

RED: NICE TA787 - oral preparation for non-hospitalised patients. To be prescribed by clinicians working in the Covid Medicines Delivery Unit only

1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)